214 related articles for article (PubMed ID: 16958197)
41. Treatment of agitation following traumatic brain injury: a review of the literature.
Levy M; Berson A; Cook T; Bollegala N; Seto E; Tursanski S; Kim J; Sockalingam S; Rajput A; Krishnadev N; Feng C; Bhalerao S
NeuroRehabilitation; 2005; 20(4):279-306. PubMed ID: 16403996
[TBL] [Abstract][Full Text] [Related]
42. Association between droperidol use and sudden death in two patients intoxicated with illicit stimulant drugs.
Cox RD; Koelliker DE; Bradley KG
Vet Hum Toxicol; 2004 Feb; 46(1):21-3. PubMed ID: 14748411
[TBL] [Abstract][Full Text] [Related]
43. Are oral medications effective in the management of acute agitation?
Gault TI; Gray SM; Vilke GM; Wilson MP
J Emerg Med; 2012 Nov; 43(5):854-9. PubMed ID: 22541877
[TBL] [Abstract][Full Text] [Related]
44. The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia.
Reus VI; Fochtmann LJ; Eyler AE; Hilty DM; Horvitz-Lennon M; Jibson MD; Lopez OL; Mahoney J; Pasic J; Tan ZS; Wills CD; Rhoads R; Yager J
Am J Psychiatry; 2016 May; 173(5):543-6. PubMed ID: 27133416
[No Abstract] [Full Text] [Related]
45. Cardiac and cerebrovascular morbidity and mortality associated with antipsychotic medications in elderly psychiatric inpatients.
Barak Y; Baruch Y; Mazeh D; Paleacu D; Aizenberg D
Am J Geriatr Psychiatry; 2007 Apr; 15(4):354-6. PubMed ID: 17384319
[TBL] [Abstract][Full Text] [Related]
46. [Indications for, limitations, and hazards of neuroleptic agents].
Hoes MJ
Ned Tijdschr Geneeskd; 1980 Apr; 124(17):647-53. PubMed ID: 6104304
[No Abstract] [Full Text] [Related]
47. Pharmacologic management of acutely agitated pediatric patients.
Sonnier L; Barzman D
Paediatr Drugs; 2011 Feb; 13(1):1-10. PubMed ID: 21162596
[TBL] [Abstract][Full Text] [Related]
48. Factors associated with the use of physical restraints for agitated patients in psychiatric emergency rooms.
Migon MN; Coutinho ES; Huf G; Adams CE; Cunha GM; Allen MH
Gen Hosp Psychiatry; 2008; 30(3):263-8. PubMed ID: 18433659
[TBL] [Abstract][Full Text] [Related]
49. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
Turner MS; Stewart DW
J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
[TBL] [Abstract][Full Text] [Related]
50. Current attitudes regarding treatment of agitation and psychosis in dementia.
Serby MJ; Roane DM; Lantz MS; Cohen AJ; Turok A; Perlis TE
Am J Geriatr Psychiatry; 2009 Feb; 17(2):174. PubMed ID: 19155750
[No Abstract] [Full Text] [Related]
51. [Studies of risk factors and preventive care for neuroleptic malignant syndrome].
Tanii H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):177-81. PubMed ID: 17240842
[TBL] [Abstract][Full Text] [Related]
52. Midazolam in acute psychotic patients with hyperarousal.
Mendoza R; Djenderedjian AH; Adams J; Ananth J
J Clin Psychiatry; 1987 Jul; 48(7):291-2. PubMed ID: 3597332
[TBL] [Abstract][Full Text] [Related]
53. [Antipsychotic drug therapy for patients with behavioral and psychological symptoms of dementia(BPSD)].
Kudo T
Seishin Shinkeigaku Zasshi; 2007; 109(7):657-63. PubMed ID: 17969953
[No Abstract] [Full Text] [Related]
54. [Antipsychotics in geriatric institutions].
Szulik J
Vertex; 2007; 18(76):454-60. PubMed ID: 18273435
[TBL] [Abstract][Full Text] [Related]
55. Safety of medications used to treat acute agitation.
Currier GW; Allen MH; Bunney EB; Daniel DG; Francis A; Jagoda A; Zimbroff D
J Emerg Med; 2004 Nov; 27(4 Suppl):S19-24. PubMed ID: 15504614
[No Abstract] [Full Text] [Related]
56. Safety and efficacy of high-dose droperidol in agitated patients.
Szuba MP; Bergman KS; Baxter LR; Guze BH; Reynolds CA; Pelletier LR
J Clin Psychopharmacol; 1992 Apr; 12(2):144-6. PubMed ID: 1573042
[No Abstract] [Full Text] [Related]
57. Safety and effectiveness of benzodiazepines and antipsychotics for agitation in older adults in the emergency department.
Engstrom K; Mattson AE; Mara K; Silva LOJE; Bellolio F; Jeffery MM; Stanich J; Brown CS
Am J Emerg Med; 2023 May; 67():156-162. PubMed ID: 36893629
[TBL] [Abstract][Full Text] [Related]
58. Chemical agents for the sedation of agitated patients in the ED: a systematic review.
Korczak V; Kirby A; Gunja N
Am J Emerg Med; 2016 Dec; 34(12):2426-2431. PubMed ID: 27707527
[TBL] [Abstract][Full Text] [Related]
59. Abstinence, anticipation, reduction, and treatment (AART): a stepwise approach to the management of atypical antipsychotic side effects.
Kennedy A; Tapp A; Kelly WS; Kilzieh N; Wood AE
Essent Psychopharmacol; 2006; 7(1):1-14. PubMed ID: 16989288
[TBL] [Abstract][Full Text] [Related]
60. Pharmacologic management of the agitated child.
Marzullo LR
Pediatr Emerg Care; 2014 Apr; 30(4):269-75; quiz 276-8. PubMed ID: 24694885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
